

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Targeting viral entry as a strategy for... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/8-1628/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/8-1628" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Targeting viral entry as a strategy for broad-spectrum antivirals" />
    
            <meta name="og:title" content="F1000Research Article: Targeting viral entry as a strategy for broad-spectrum antivirals.">
            <meta name="og:description" content="Read the latest article version by Michela Mazzon, Mark Marsh, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="21600">
            <meta name="article-id" content="19694">
            <meta name="dc.title" content="Targeting viral entry as a strategy for broad-spectrum antivirals">
            <meta name="dc.description" content="The process of entry into a host cell is a key step in the life cycle of most viruses. In recent years, there has been a significant increase in our understanding of the routes and mechanisms of entry for a number of these viruses. This has led to the development of novel broad-spectrum antiviral approaches that target host cell proteins and pathways, in addition to strategies focused on individual viruses or virus families. Here we consider a number of these approaches and their broad-spectrum potential.">
            <meta name="dc.subject" content="Antiviral, Virus entry, Endocytosis, Virus fusion, Broad-spectrum, Host-targeted">
            <meta name="dc.creator" content="Mazzon, Michela">
            <meta name="dc.creator" content="Marsh, Mark">
            <meta name="dc.date" content="2019/09/12">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.19694.1">
            <meta name="dc.source" content="F1000Research 2019 8:1628">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Antiviral">
            <meta name="prism.keyword" content="Virus entry">
            <meta name="prism.keyword" content="Endocytosis">
            <meta name="prism.keyword" content="Virus fusion">
            <meta name="prism.keyword" content="Broad-spectrum">
            <meta name="prism.keyword" content="Host-targeted">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2019/09/12">
            <meta name="prism.volume" content="8">
            <meta name="prism.number" content="1628">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.19694.1">
            <meta name="prism.url" content="https://f1000research.com/articles/8-1628">
            <meta name="citation_title" content="Targeting viral entry as a strategy for broad-spectrum antivirals">
            <meta name="citation_abstract" content="The process of entry into a host cell is a key step in the life cycle of most viruses. In recent years, there has been a significant increase in our understanding of the routes and mechanisms of entry for a number of these viruses. This has led to the development of novel broad-spectrum antiviral approaches that target host cell proteins and pathways, in addition to strategies focused on individual viruses or virus families. Here we consider a number of these approaches and their broad-spectrum potential.">
            <meta name="citation_description" content="The process of entry into a host cell is a key step in the life cycle of most viruses. In recent years, there has been a significant increase in our understanding of the routes and mechanisms of entry for a number of these viruses. This has led to the development of novel broad-spectrum antiviral approaches that target host cell proteins and pathways, in addition to strategies focused on individual viruses or virus families. Here we consider a number of these approaches and their broad-spectrum potential.">
            <meta name="citation_keywords" content="Antiviral, Virus entry, Endocytosis, Virus fusion, Broad-spectrum, Host-targeted">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Michela Mazzon">
            <meta name="citation_author_institution" content="MRC Laboratory for Molecular Cell Biology, University College London, London, UK">
            <meta name="citation_author" content="Mark Marsh">
            <meta name="citation_author_institution" content="MRC Laboratory for Molecular Cell Biology, University College London, London, UK">
            <meta name="citation_publication_date" content="2019/09/12">
            <meta name="citation_volume" content="8">
            <meta name="citation_publication_number" content="1628">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.19694.1">
            <meta name="citation_firstpage" content="1628">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/8-1628/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/8-1628.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=21600 /> <input type=hidden id=articleId name=articleId value=19694 /> <input type=hidden id=xmlUrl value="/articles/8-1628/v1/xml"/> <input type=hidden id=xmlFileName value="-8-1628-v1.xml"> <input type=hidden id=article_uuid value=4b37e09d-cd84-4ba6-b517-b019c4156973 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Targeting viral entry as a strategy for broad-spectrum antivirals"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.19694.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.19694.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/8-1628"
  },
  "headline": "Targeting viral entry as a strategy for broad-spectrum antivirals",
  "datePublished": "2019-09-12T11:42:04",
  "dateModified": "2019-09-12T11:42:04",
  "author": [
    {
      "@type": "Person",
      "name": "Michela Mazzon"
    },    {
      "@type": "Person",
      "name": "Mark Marsh"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "The process of entry into a host cell is a key step in the life cycle of most viruses. In recent years, there has been a significant increase in our understanding of the routes and mechanisms of entry for a number of these viruses. This has led to the development of novel broad-spectrum antiviral approaches that target host cell proteins and pathways, in addition to strategies focused on individual viruses or virus families. Here we consider a number of these approaches and their broad-spectrum potential."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/8-1628",
            "name": "Targeting viral entry as a strategy for broad-spectrum antivirals"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Targeting viral entry as a strategy for broad-spectrum antivirals </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=21600 data-id=19694 data-downloads="" data-views="" data-scholar="10.12688/f1000research.19694.1" data-recommended="" data-doi="10.12688/f1000research.19694.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/8-1628/v1/pdf?article_uuid=4b37e09d-cd84-4ba6-b517-b019c4156973" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-19694-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-19694-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-19694-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Mazzon M and Marsh M. Targeting viral entry as a strategy for broad-spectrum antivirals [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):1628 (<a class=new-orange href="https://doi.org/10.12688/f1000research.19694.1" target=_blank>https://doi.org/10.12688/f1000research.19694.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-19694-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=19694 id=track-article-signin-19694 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/19694?target=/articles/8-1628">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=21600 /> <input name=articleId type=hidden value=19694 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Targeting viral entry as a strategy for broad-spectrum antivirals</h1><span class=other-info> [version 1; peer review: 3 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:m.mazzon@ucl.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Michela Mazzon</span></a><a href="https://orcid.org/0000-0002-2462-9925" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-2462-9925</div>,&nbsp;</span><span class=""><a href="mailto:m.marsh@ucl.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Mark Marsh</span></a><a href="https://orcid.org/0000-0002-0213-3259" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-0213-3259</div></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:m.mazzon@ucl.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Michela Mazzon</span></a><a href="http://orcid.org/0000-0002-2462-9925" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-2462-9925</div>,&nbsp;</span><span class=""><a href="mailto:m.marsh@ucl.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Mark Marsh</span></a><a href="http://orcid.org/0000-0002-0213-3259" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-0213-3259</div></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 12 Sep 2019 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.19694.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> MRC Laboratory for Molecular Cell Biology, University College London, London, UK<br/> <p> <div class=margin-bottom> Michela Mazzon <br/> <span>Roles: </span> Conceptualization, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Mark Marsh <br/> <span>Roles: </span> Conceptualization, Funding Acquisition, Supervision, Writing  Original Draft Preparation, Writing  Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=56436-53253></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=56437-53255></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=56438-53254></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> The process of entry into a host cell is a key step in the life cycle of most viruses. In recent years, there has been a significant increase in our understanding of the routes and mechanisms of entry for a number of these viruses. This has led to the development of novel broad-spectrum antiviral approaches that target host cell proteins and pathways, in addition to strategies focused on individual viruses or virus families. Here we consider a number of these approaches and their broad-spectrum potential. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Antiviral, Virus entry, Endocytosis, Virus fusion, Broad-spectrum, Host-targeted </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Michela Mazzon (<a href="mailto:m.mazzon@ucl.ac.uk">m.mazzon@ucl.ac.uk</a>) <br> Mark Marsh (<a href="mailto:m.marsh@ucl.ac.uk">m.marsh@ucl.ac.uk</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding authors:</b> Michela Mazzon, Mark Marsh </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The authors are supported by Medical Research Council funding to the MRC-UCL LMCB University Unit (MC_UU_12018/1). <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2019 Mazzon M and Marsh M. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Mazzon M and Marsh M. Targeting viral entry as a strategy for broad-spectrum antivirals [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):1628 (<a href="https://doi.org/10.12688/f1000research.19694.1" target=_blank>https://doi.org/10.12688/f1000research.19694.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 12 Sep 2019, <b>8</b>(F1000 Faculty Rev):1628 (<a href="https://doi.org/10.12688/f1000research.19694.1" target=_blank>https://doi.org/10.12688/f1000research.19694.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 12 Sep 2019, <b>8</b>(F1000 Faculty Rev):1628 (<a href="https://doi.org/10.12688/f1000research.19694.1" target=_blank>https://doi.org/10.12688/f1000research.19694.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d8838e148>Introduction</h2><p class="" id=d8838e151>Although not a guarantee of successful infection, entry into a host cell is a critical stage in the life of a virus<sup><a href="#ref-1">1</a>,<a href="#ref-2">2</a></sup>. Once inside a cell, a virus still needs to overcome a hostile environment, evade immune responses, and subvert a range of cellular proteins and pathways to facilitate its replication. However, finding a permissive cell and delivering genetic information into its cytoplasm, and in some cases nucleus, is the first necessary step for viral infection. This has at least two important implications from a prophylactic and/or therapeutic perspective. The first is that blocking viral entry stops infection early on, preventing viral replication. The second is that because many viruses exploit cellular endocytic mechanisms to initiate internalization and infection, and cells have just a few such mechanisms, inhibiting these pathways may affect many different viruses, greatly expanding our currently limited antiviral portfolio.</p><p class="" id=d8838e161>It is now well established that, after initial attachment to the cell surface, many viruses, both enveloped and non-enveloped, exploit changes in environmental conditions, such as pH, interaction with a cellular receptor, or the activity of proteolytic enzymes, to trigger conformational changes in key proteins that mediate cell membrane penetration<sup><a href="#ref-1">1</a><a href="#ref-3">3</a></sup>. For enveloped viruses, the virus lipid bilayer needs to fuse with the cellular limiting membrane (either the plasma membrane or the membrane of endocytic organelles) to release the viral genome, and this is mediated by viral envelope proteins. For non-enveloped viruses, genome release is affected by viral capsid proteins that trigger cell membrane penetration and genome release.</p><p class="" id=d8838e171>While some viruses fuse directly at the plasma membrane, the majority use endocytic mechanisms to reach intracellular compartments, with clathrin-mediated endocytosis (CME), caveolin-mediated endocytosis, macropinocytosis, and phagocytosis currently being the best characterized of these pathways. CME in particular is exploited by numerous viruses, including alphaviruses, flaviviruses, orthomyxoviruses, and rhabdoviruses<sup><a href="#ref-1">1</a>,<a href="#ref-2">2</a></sup>, while macropinocytosis is linked to the uptake of larger viruses, such as poxviruses and filoviruses, that do not fit into clathrin-coated vesicles<sup><a href="#ref-4">4</a><a href="#ref-6">6</a></sup>. Thus, inhibiting these pathways might be expected to impact on a range of different viruses.</p><p class="" id=d8838e188>In this review, we summarize the main therapeutic approaches that target different stages of viral entry (<a href="#f1">Figure 1</a>), either by inhibiting virus-specific interactions or by blocking conserved cellular mechanisms that viruses exploit to enter cells. This latter tactic is indicative of a change of focus for viral therapeutics, combining more traditional approaches directed at specific viruses with novel cell-targeted strategies with broad-spectrum potential.</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/21600/a5436b92-3eeb-4c08-b3c6-50363f75efd0_figure1.gif"><img alt="a5436b92-3eeb-4c08-b3c6-50363f75efd0_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/21600/a5436b92-3eeb-4c08-b3c6-50363f75efd0_figure1.gif"></a><div class=caption><h3>Figure 1. Schematic representing the main stages of viral entry.</h3><p id=d8838e205>Processes inhibited by the antivirals described (attachment, receptor binding, endocytosis, trafficking, endosomal acidification, and fusion) are indicated.</p></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d8838e215>Inhibition of cell adhesion</h2><p class="" id=d8838e218>The first step in viral entry is virus adhesion to the cell surface. Regardless of the requirement to engage specific receptors, viruses often use non-specific electrostatic interactions with negatively charged sugars to attach to a cell surface until they encounter a specific entry receptor. Negatively charged heparan sulfate proteoglycans (HSPGs) are expressed on the surface of most eukaryotic cells and have been shown to be required for the binding of many viruses, including human immunodeficiency virus (HIV), herpes simplex virus (HSV), human cytomegalovirus (HCMV), human papilloma virus (HPV), respiratory syncytial virus (RSV), and flaviviruses<sup><a href="#ref-7">7</a><a href="#ref-10">10</a></sup>. Inhibition of these interactions through the development of decoy particles mimicking these molecules (heparin, sulfated polysaccharides, or sulfonic acid-coated nanoparticle) can effectively prevent infection <i>in vitro</i>. However, limited efficacy is seen <i>in vivo</i>, possibly owing to the poor bioavailability of these formulations. While high-molecular-weight molecules with a high degree of sulfation have the highest antiviral activity <i>in vitro</i>, these compounds tend to bind to plasma proteins and have poor bioavailability<sup><a href="#ref-11">11</a>,<a href="#ref-12">12</a></sup>. Conversely, low-molecular-weight compounds have better bioavailability and are more effective <i>in vivo</i><sup><a href="#ref-13">13</a></sup> but are also associated with higher cytotoxicity, possibly owing to detergent effects on cellular membranes.</p><p class="" id=d8838e251>Virucidal activity may also be required to increase <i>in vivo</i> efficacy. Cagno <i>et al</i>. have shown that nanoparticles carrying long, flexible linkers mimicking HSPGs can simultaneously bind multiple sites on a virus and cause permanent distortion of the virion structure. This virucidal activity was sufficient to inhibit RSV infection in mice, suggesting that particles mimicking the negatively charged cellular surfaces to which viruses bind have the potential to be effective antivirals, as long as they include the capacity to inactivate viral infectivity<sup><a href="#ref-14">14</a></sup>.</p><p class="" id=d8838e264>It is important to note that sulfated polysaccharides are also known to have anticoagulant activity, but derivatives exist that do not show these properties <i>in vivo</i> at therapeutic doses (e.g. fucoidan, galactan, and xylomannan)<sup><a href="#ref-12">12</a></sup>.</p><p class="" id=d8838e274>Other molecules that target common cellular components also have the potential to interfere with attachment and to have broad-spectrum antiviral activity. Cyanovirin-N is a naturally occurring lectin that has been shown to inhibit the attachment of HIV<sup><a href="#ref-15">15</a></sup> and Ebola virus (EBOV) to cells<sup><a href="#ref-16">16</a></sup>, most likely by binding to high-mannose oligosaccharides on the viral glycoproteins. The same mode of action may prevent infection by other viruses, though this remains to be tested, as does <i>in vivo</i> efficacy<i>.</i></p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d8838e293>Inhibition of receptor binding</h2><div class=section><a name=d8838e296 class=n-a></a><h3 class=section-title>Cell surface receptors</h3><p class="" id=d8838e301>While often involved in virus adhesion to cell surfaces, negatively charged sugars associated with cell surface glycoproteins and glycolipids can also act as virus receptors (e.g. sialic acid for influenza) or enable an interaction of sufficient strength to allow internalization of a virus by endocytosis, as may be the case for flaviviruses and filoviruses<sup><a href="#ref-17">17</a>,<a href="#ref-18">18</a></sup>. Both virus- and cell-targeted approaches have been studied to prevent the interaction between influenza hemagglutinin (HA) and sialic acids (SA) on glycoprotein and glycolipid receptors. Virus-targeted strategies include the use of protease inhibitors that block the processing of HA and peptides or small molecules that interfere with HA binding to SA. The most promising cell-targeted strategy is the attachment inhibitor DAS181, a recombinant protein made of a sialidase catalytic domain (which removes SA from influenza receptors) and a mucosal cell-surface anchoring sequence. This compound, highly potent <i>in vitro</i> (IC<sub>50</sub> between 0.04 and 0.9 nM), has been shown to be non-toxic to cells and to be effective <i>in vivo</i> when administered pre- and post-exposure<sup><a href="#ref-19">19</a></sup>. A phase II trial showed reduction of viral load over 5 days administration at 10 mg/kg/day<sup><a href="#ref-20">20</a></sup>, and phase III trials are ongoing. A comprehensive overview of inhibitors of HASA interaction is presented by<sup><a href="#ref-12">12</a>,<a href="#ref-21">21</a></sup>.</p><p class="" id=d8838e336>For other cell-surface virus receptors, maraviroc (FDA approved in 2007) is currently the only drug that inhibits viral entry. Its target is CCR5, the major co-receptor required for HIV infection of CD4-positive cells<sup><a href="#ref-22">22</a></sup>. Maraviroc was developed by Pfizer through screening of their compound library and subsequent additional screens to improve activity and pharmacological properties of the initial hit compound. In combination with at least two additional anti-retroviral drugs, maraviroc is currently used in HIV-infected patients showing resistance to other compounds<sup><a href="#ref-23">23</a></sup>. While some limited development of resistance has been observed, the frequency of this is not clear<sup><a href="#ref-22">22</a></sup> and is usually associated with multiple mutations in the HIV envelope protein that generally cause a significant decrease in viral fitness<sup><a href="#ref-24">24</a></sup>. This notion, that viral adaptations to overcome inhibitors acting through cellular targets can weaken the virus, is a potentially significant and interesting advantage of host-targeted antiviral strategies.</p><p class="" id=d8838e355>An alternative tactic is to inhibit the synthesis of cellular membrane glycoproteins that function as receptors for specific viruses. Cyclotriazadisulfonamide (CADA), a small-molecule inhibitor of HIV replication, has been found to specifically inhibit the synthesis of the HIV receptor CD4 by binding to the protein signal sequence in the Sec61 translocon during the co-translational insertion of the nascent protein into the ER membrane<sup><a href="#ref-25">25</a></sup>. Decreased levels of CD4 render potential host cells refractory to HIV-1 infection and presumably HIV-2, HHV6, and any other viruses that use CD4 as a receptor. Whether this approach is effective <i>in vivo</i> and whether it can be developed to inhibit the synthesis of a broader range of virus receptors remains to be seen (see <a href="#ref-25">25</a> for a discussion of evidence for other compounds that inhibit the synthesis of specific cell-surface proteins).</p><p class="" id=d8838e368>Inhibiting the interaction of a virus with target cells is also one of the main modes of action of antibodies, and the identification and generation of such antibodies remain major strategies for antiviral immunotherapies. The development of small molecules that mimic the effect of antibodies and can be administered orally also has potential. Scientists from Janssen developed such an approach starting from the identification of a broadly neutralizing antibody, bnAbCR6261, that targets a conserved region in the stem of influenza HA. They then used a displacement screening strategy to identify small molecules that could bind to the same region as the antibody. Further medicinal chemistry on the most promising hit led to compound JNJ4796, a benzylpiperazine derivative able to inhibit influenza infection in 3D cultures of human bronchial epithelial cells and in a mouse model. Encouragingly, protection from lethal challenge was seen after oral administration in this latter model<sup><a href="#ref-26">26</a></sup>.</p></div><div class=section><a name=d8838e376 class=n-a></a><h3 class=section-title>Intracellular receptors</h3><p class="" id=d8838e381>While most virus receptors are found at the cell surface, some viruses also interact with receptors inside endo-lysosomal compartments following their endocytosis. For example, EBOV uses the lysosomal protein Niemann Pick C-1 (NPC-1)<sup><a href="#ref-18">18</a></sup>, while Lassa fever virus has been shown to interact with LAMP1, another lysosomal protein<sup><a href="#ref-27">27</a></sup>. Antibody targeting of these interactions is complicated by the intracellular localization of the receptors. However, an exciting technology that has recently been expanded to viral infection is the development of bispecific antibodies. By linking the variable regions of an antibody recognizing the EBOV glycoprotein (GP) glycan cap (FV-M09) with the variable regions of antibodies recognizing either NPC-1 (mAb-548) or the NPC-1 binding region on GP (MR72), Wec <i>et al</i>. showed that this bispecific antibody bound to EBOV is internalized into endo-lysosomal compartments where it potently blocks Ebola interaction with its intracellular receptor<sup><a href="#ref-28">28</a></sup>. This strategy, already tested for HIV<sup><a href="#ref-29">29</a></sup>, has been shown to protect mice, even when administered 2 days after challenge with EBOV<sup><a href="#ref-28">28</a></sup>.</p><p class="" id=d8838e408>Small-molecule inhibitors of NPC-1 that accumulate in endosomal compartments like U18666A<sup><a href="#ref-18">18</a></sup> and the piperazine-derivative 3.47<sup><a href="#ref-30">30</a></sup> also effectively block EBOV infection <i>in vitro</i>, the first by inducing cholesterol accumulation in the lysosomes and the latter by directly interacting with NPC-1.</p></div><div class=section><a name=d8838e423 class=n-a></a><h3 class=section-title>Non-enveloped viruses</h3><p class="" id=d8838e428>Compounds also have been developed that selectively bind to non-enveloped virus capsid proteins to prevent interaction with cellular receptors or uncoating. One example is the enterovirus capsid inhibitor pocapavir<sup><a href="#ref-31">31</a></sup>, which has been tested as an investigational drug to treat neonatal viral sepsis<sup><a href="#ref-32">32</a></sup> and has also been trialed against the spread of attenuated poliovirus from vaccinated individuals<sup><a href="#ref-11">11</a></sup>. Pocapavir and other capsid binders fit into a hydrophobic pocket in the viral particle, preventing conformational changes required for uncoating<sup><a href="#ref-33">33</a></sup>, but have the disadvantage of selecting for drug-resistant mutants. More recently, a conserved VP1VP3 interprotomer interface in the viral capsid, critical for the conformational changes necessary for RNA release, has been proposed as an alternative druggable target. Compounds binding to this interface have been shown to be active against a larger number of enteroviruses and also against rhinoviruses, though their ability to induce resistant variants has yet to be investigated<sup><a href="#ref-34">34</a></sup>. Tryptophan dendrimers that target the 5-fold-axis of the enterovirus-A71 capsid have also been shown to have antiviral potential <i>in vitro</i> by preventing virus interaction with the (co-)receptors PSGL1 and heparan sulfate<sup><a href="#ref-35">35</a></sup>.<b></b></p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d8838e464>Inhibition of internalization</h2><p class="" id=d8838e467>For viruses that do not penetrate directly at the plasma membrane, endocytosis is an essential step in the entry process. Endocytosis can be blocked by compounds that interfere with signaling cascades necessary to activate endocytosis or that inhibit the endocytosis machinery directly. The PI3K-AKT signaling pathway, for instance, has been shown to be required by a variety of viruses<sup><a href="#ref-36">36</a>,<a href="#ref-37">37</a></sup>, and its inhibition can prevent infection <i>in vitro</i><sup><a href="#ref-6">6</a></sup>. Similarly, vaccinia virus (VV) entry requires signaling through epidermal growth factor receptors (EGFR), serine/threonine kinases, protein kinase C, and p21-activated kinase 1 in addition to PI3K, and entry of at least some VV strains is sensitive to the tyrosine kinase inhibitor Genistein<sup><a href="#ref-38">38</a></sup>. However, studies of their effectiveness <i>in vivo</i> are limited. While there is evidence that preventing PI3K/AKT activation reduces pathogenesis in mice infected with the alphavirus Ross River, this is likely to be due to post-entry effects on virus replication and cellular metabolism<sup><a href="#ref-37">37</a></sup>.</p><p class="" id=d8838e494>A number of research compounds exist that block endocytosis directly, including PitStop, which inhibits the formation of clathrin-coated pits<sup><a href="#ref-39">39</a></sup>, as well as Dynasore<sup><a href="#ref-40">40</a></sup> and the more potent derivative Dyngo-4a<sup><a href="#ref-41">41</a></sup>, which interfere with dynamin. While these compounds have been shown to inhibit the entry of various viruses <i>in vitro</i>, they have not been used therapeutically as antivirals. A study by Harper <i>et al</i>. showed that Dyngo-4a can inhibit botulinum neurotoxin type A endocytosis in neurons <i>in vitro</i>; however, <i>in vivo</i> administration only delayed the onset of symptoms by ~3 hours in 60% of infected mice. Encouragingly, animals treated with Dyngo-4a did not show signs of toxicity at the concentrations tested<sup><a href="#ref-42">42</a></sup>. Whether higher concentrations are required to see a stronger effect <i>in vivo,</i> whether these have higher toxicity (because of either inhibition of endocytosis or off-target effects), and whether virus infection is affected requires further investigation. Several other compounds including chlorpromazine, chloroquine, and Arbidol have also been shown to inhibit endocytosis and have an antiviral effect <i>in vitro</i><sup><a href="#ref-43">43</a>,<a href="#ref-44">44</a></sup>, but efficacy <i>in vivo</i> has not yet been reported.</p><p class="" id=d8838e542>In a recent study, starting from phenotypic screening with representatives of different virus families, we identified two compounds, niclosamide and Tyrphostin A9, with very broad-spectrum antiviral activity, affecting different stages of virus replication, including endocytosis<sup><a href="#ref-45">45</a></sup>. The most likely mode of action is through dissipation of proton gradients and inhibition of ATP synthesis<sup><a href="#ref-46">46</a><a href="#ref-48">48</a></sup>, which impact on multiple cellular pathways. However, using endocytosis assays, we were able to show that CME of the alphavirus Semliki Forest virus and of fluorescently labeled transferrin was significantly reduced by both compounds<sup><a href="#ref-45">45</a></sup>. While the pharmacokinetic properties of niclosamide prevent its accumulation in the blood<sup><a href="#ref-49">49</a></sup>, Tyrphostin A9 had a better profile and showed some ability to inhibit Zika virus infection in a mouse model<sup><a href="#ref-45">45</a></sup>. Tyrphostin A9 is also a general tyrosine kinase inhibitor and is likely to affect a variety of kinases involved in viral life cycles. Interestingly, Tyrphostin A23 has also been shown to inhibit CME by preventing the interaction between receptor tyrosine-based endocytic signals and the mu2 subunit of the AP-2 adaptor complex<sup><a href="#ref-46">46</a></sup>. Although the chemical properties of Tyrphostin A9 make it unlikely to become a drug, this work provided proof of concept that entry inhibitors with broad-spectrum antiviral activity <i>in vitro</i> can also exhibit antiviral activity <i>in vivo</i>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d8838e582>Inhibition of fusion</h2><p class="" id=d8838e585>For enveloped viruses, fusion is the next necessary step that allows a virus to release its genome into the cytoplasm. Fusion is mediated by virally encoded envelope glycoproteins displayed on the virion surface. Viruses require cellular cues to induce conformational changes in these envelope glycoproteins to initiate fusion with cellular membranes, in some cases the plasma membrane, and, for many viruses, endosomal membranes. For some viruses that fuse at the cell surface, such as HIV, receptor engagement provides the cue that initiates the envelope glycoprotein conformational changes and fusion<sup><a href="#ref-50">50</a></sup>. But for many viruses a common cue is the acidic pH of endosomal environments<sup><a href="#ref-1">1</a>,<a href="#ref-3">3</a>,<a href="#ref-51">51</a></sup>. Weak bases, including the antimalarial drug chloroquine, and carboxylic ionophores such as monensin, can inhibit endosomal acidification and block infection by a wide range of viruses <i>in vitro</i><sup><a href="#ref-1">1</a>,<a href="#ref-52">52</a>,<a href="#ref-53">53</a></sup>, but, with the exception of amantadine, few studies have tested their efficacy <i>in vivo.</i> The weak base amantadine and some amantadine analogues have been used against influenza virus infection<sup><a href="#ref-54">54</a></sup>, but their activity is directed through inhibition of the viral M2 protein, rather than inhibition of endosomal acidification, and viruses rapidly evolve resistance<sup><a href="#ref-55">55</a></sup>.</p><p class="" id=d8838e626>An alternative cue to low pH is proteolytic cleavage of envelope proteins by endosomal proteases, as used by filoviruses, such as EBOV, and coronaviruses. For EBOV, proteolytic cleavage by endo-lysosomal cathepsins is essential to generate a form of the envelope glycoprotein that can bind NPC-1<sup><a href="#ref-56">56</a></sup>, and inhibitors of these proteases can effectively abrogate EBOV infection, although none of these compounds is currently approved for use in humans and selectivity remains an issue. Recently, a role for the two-pore calcium channel 2 (TPC2) in EBOV infection was shown. While the exact role of TPC2 is not yet clear, it is likely to control cues in the endo-lysosomal environment necessary for EBOV fusion<sup><a href="#ref-57">57</a></sup>. Interestingly, small molecules that target TPC2 inhibit EBOV infection both <i>in vitro</i> and <i>in vivo</i><sup><a href="#ref-57">57</a><a href="#ref-59">59</a></sup>. These TPC2 antagonists, including tetrandrine, also inhibit MERS coronaviruses<sup><a href="#ref-60">60</a></sup>. Similarly, apilimod, a compound that targets a phosphatidylinositol-3-phosphate 5-kinase (PIKfyve) involved in endosomal trafficking, also inhibits EBOV infection by blocking the transport of Ebola particles into NPC-1-containing endo-lysosomes<sup><a href="#ref-61">61</a></sup>. Whether these compounds act on other viruses that penetrate from late endosomes remains unclear. Elevation of endosomal potassium may also provide cues that activate the fusion proteins of some bunyaviruses and influenza viruses, and infection can be restricted by compounds that inhibit endosomal potassium channels<sup><a href="#ref-62">62</a></sup>. Together, these studies indicate that combining perturbants of the endocytic system might offer an effective approach to inhibiting a range of different viruses.</p><p class="" id=d8838e662>Some virus-specific fusion inhibitors also exist. Enfuvirtide, used in combination with other anti-retroviral therapies for the treatment of HIV, is a peptide that binds the heptad repeat region 2 in the gp41 subunit of the HIV envelope glycoprotein and prevents formation of the so-called stable six-helix bundle that is crucial for membrane fusion<sup><a href="#ref-63">63</a></sup>. Fusion inhibitors that stabilize metastable conformations of the RSV fusion protein have also been developed<sup><a href="#ref-64">64</a>,<a href="#ref-65">65</a></sup>. Though none of these is currently approved for use, a number are in clinical trials. Peptides that block the fusion of other paramyxoviruses, including measles, Nipah, and Hendra viruses, by interfering with the viral envelope proteins have also been developed and shown to have antiviral activity <i>in vivo</i><sup><a href="#ref-57">57</a>,<a href="#ref-66">66</a>,<a href="#ref-67">67</a></sup>. A similar approach using peptides or small molecules has also shown promise against flaviviruses (West Nile and dengue viruses)<sup><a href="#ref-68">68</a>,<a href="#ref-69">69</a></sup>.</p><p class="" id=d8838e695>An alternative approach to inhibiting fusion is to interfere with the biophysical properties of membranes through compounds that intercalate into cellular membranes and in so doing alter their rigidity or curvature. This can be achieved with certain lipids in tissue culture systems<sup><a href="#ref-70">70</a>,<a href="#ref-71">71</a></sup>. A similar effect may underlie the action of cellular proteins called interferon-inducible transmembrane proteins (IFITMs). Although the exact mode of action of these proteins (three in humans, IFITM 13) remains unclear, their effectiveness against an extraordinary variety of viruses suggests that interfering with the composition/biophysical properties of cellular membranes involved in virus entry can be a potent broad-spectrum antiviral strategy<sup><a href="#ref-64">64</a>,<a href="#ref-72">72</a>,<a href="#ref-73">73</a></sup>. However, recent work by Buchrieser <i>et al</i>. indicates that IFITM expression can interfere with placental development by inhibiting syncytin-mediated syncytiotrophoblast formation, indicating that these proteins can interfere in cellular fusion reactions<sup><a href="#ref-74">74</a></sup>. Whether they impact on other cellcell fusion events or intracellular membrane fusion processes remains to be established.</p><p class="" id=d8838e723>Using phenotypic screens, we and others have identified a number of compounds that, because of their biophysical properties, are likely to intercalate into the endosomal membranes and prevent fusion<sup><a href="#ref-45">45</a>,<a href="#ref-75">75</a></sup>. This is possibly the mode of action of selective estrogen receptor modulators (SERMs) and similar amphipathic compounds, including amiodarone<sup><a href="#ref-76">76</a>,<a href="#ref-77">77</a></sup> and amodiaquine<sup><a href="#ref-78">78</a></sup>, although it is possible that these compounds may also alter endosomal pH. However, the concentrations required to achieve similar antiviral effects <i>in vivo</i> are likely to be high, and the risk of side effects significant.</p><p class="" id=d8838e747>Interfering with viral rather than cellular membranes is also a promising broad-spectrum antiviral approach for enveloped viruses. LJ001 is a small molecule which oxidizes the unsaturated phospholipids of both cellular and viral membranes<sup><a href="#ref-79">79</a></sup>. This is likely to alter membrane curvature and fluidity, preventing fusion. Interestingly, while affecting both cellular and viral membranes, only the latter are significantly affected, most likely because the cellular membrane can rapidly replace damaged lipids, a property that viruses do not share<sup><a href="#ref-80">80</a></sup>. This makes LJ001 effective <i>in vitro</i> against a wide variety of viruses including influenza, and with very limited toxicity. Unfortunately, little effectiveness was seen <i>in vivo</i>, owing to a short half-life (~4 hours) and low concentration of the compound in serum. Furthermore, LJ001 needs light to activate, which limits its application <i>in vivo</i>. Nevertheless, analogues with improved stability and pharmacokinetics are being developed<sup><a href="#ref-79">79</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d8838e776>Conclusions and future outlook</h2><p class="" id=d8838e779>Host cell entry is a crucial step for most viruses, and preventing entry provides a clear early opportunity to control infection. As viruses use just a few conserved cellular pathways for entry, targeting cellular proteins rather than viral proteins has emerged as a promising antiviral strategy. Indeed, many of the approaches that have been investigated in the past few years target host rather than viral components, even when the target is highly selective for one specific virus, as is the case for maraviroc<sup><a href="#ref-22">22</a></sup>. This is in line with a recent trend in the development of antiviral strategies<sup><a href="#ref-51">51</a>,<a href="#ref-81">81</a></sup>. To date, small-molecule interference with viral infection has tended to focus on specific viruses and viral proteins. For a few viruses, HIV, HCV, and herpes, for example, this approach has been very effective. In the case of HIV at least, combinations of compounds targeting key viral enzymes essential for completion of the viral life cycle (e.g. HIV <i>Pol-</i>encoded reverse transcriptase, integrase, and protease) control virus replication in infected patients, substantially improve longevity and life quality, and are now being adopted as pre- and post-exposure prophylactics to prevent virus infection<sup><a href="#ref-82">82</a>,<a href="#ref-83">83</a></sup>. Similarly, nucleoside analogues and protease inhibitors active against HCV have the potential to cure what would otherwise be a lifelong chronic infection often resulting in cirrhosis and liver cancer and only treatable by liver transplantation<sup><a href="#ref-84">84</a></sup>. Though highly successful, these drugs are limited to the treatment of single viruses and are prone to viral resistance mutations rendering them ineffective.</p><p class="" id=d8838e807>Conversely, very few drugs are available for use against the majority of other viruses. This is a major concern given the increased emergence (or re-emergence) of new pathogens, often from zoonotic infections (e.g. SARS and MERS), and the enlarged geographical distribution of insect-vectored viruses caused by environmental changes (e.g. Zika and dengue<sup><a href="#ref-85">85</a></sup>). Under these circumstances, targeting host cell pathways as opposed to viral proteins is a viable option for controlling infection. One argument against this approach is the potential toxicity of targeting host cell pathways. Toxicity could be due to the inhibition of critical cellular pathways as well as to off-target effects. However, most of the virus infections that might benefit from this approach establish acute infections for which drug administration could be as short as a few days. Moreover, most drugs currently on the market against a range of diseases target host cell pathways with limited, or acceptable, side effects. Another argument is that virus-targeted antivirals seem to be more potent than cell-targeted ones. This concern is counter-balanced by the potential for broad-spectrum effectiveness of many cell-targeted approaches, which may be critical to rapidly contain emerging viruses. Because of lower potency, these compounds might not stop virus infection completely, but several studies indicate that, in general, any capacity to reduce the viral load gives patients a better chance of establishing effective immune control<sup><a href="#ref-86">86</a><a href="#ref-89">89</a></sup>.</p><p class="" id=d8838e821>As with the application of anti-retroviral therapies, compounds targeting entry and replication could be used in combination; for example, compounds that inhibit CME could be administered together with compounds that inhibit macropinocytosis and/or endosomal acidification in order to broaden the range of viruses affected and/or increase the effectiveness of the treatment. Although we have focused on virus entry, targeting other cellular pathways, such as ER-associated glycoprotein synthesis, also offers exciting potential for broad-spectrum antiviral development that could broaden potential combination therapies<sup><a href="#ref-90">90</a></sup>. This strategy could also reduce toxicity by allowing the use of lower concentrations of each component in complex formulations.</p><p class="" id=d8838e828>While many successful approaches have been described <i>in vitro</i>, an outstanding question is whether they are also effective <i>in vivo</i>. In particular for host-targeted approaches, it will be important to determine safe thresholds that separate an effective decrease in viral load from toxicity. The limited <i>in vivo</i> efficacy of many treatments to date may be due to the pharmacokinetics and bioavailability of the compounds, or possibly to the limited range of conditions that are generally tested <i>in vivo</i> due to the costs, logistics, and restrictions on animal studies. Limited availability of adequate small models that recapitulate disease also contributes to the problem. While more work remains to be done, the approval of drugs like maraviroc and enfuvirtide suggests that targeting viral entry is a promising antiviral strategy warranting further investigation and the integration of different disciplines, from virology to medicinal chemistry.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d8838e847 class=n-a></a><h2 class=main-title id=d8838e849>Acknowledgements</h2><p class="" id=d8838e852>We thank Giorgia Siriaco (University College London) for careful reading of the manuscript and members of the Marsh lab for ongoing discussion on the topics addressed in this article.</p></div><div class=back-section><a name=d8838e856 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d9440>References</h2><div class="section ref-list"><a name=d8838e856 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d8838e863 class=n-a></a>Marsh M, Helenius A: Virus entry: open sesame. <i>Cell.</i> 2006; <b>124</b>(4): 72940. <a target=xrefwindow id=d8838e871 href="http://www.ncbi.nlm.nih.gov/pubmed/16497584">PubMed Abstract </a> | <a target=xrefwindow id=d8838e874 href="https://doi.org/10.1016/j.cell.2006.02.007">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d8838e883 class=n-a></a>Mercer J, Schelhaas M, Helenius A: Virus entry by endocytosis. <i>Annu Rev Biochem.</i> 2010; <b>79</b>: 80333. <a target=xrefwindow id=d8838e891 href="http://www.ncbi.nlm.nih.gov/pubmed/20196649">PubMed Abstract </a> | <a target=xrefwindow id=d8838e894 href="https://doi.org/10.1146/annurev-biochem-060208-104626">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d8838e903 class=n-a></a>Snchez-San Martn C, Liu CY, Kielian M: Dealing with low pH: entry and exit of alphaviruses and flaviviruses. <i>Trends Microbiol.</i> 2009; <b>17</b>(11): 51421. <a target=xrefwindow id=d8838e911 href="http://www.ncbi.nlm.nih.gov/pubmed/19796949">PubMed Abstract </a> | <a target=xrefwindow id=d8838e914 href="https://doi.org/10.1016/j.tim.2009.08.002">Publisher Full Text </a> | <a target=xrefwindow id=d8838e917 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2783195">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1108808"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8838e926 class=n-a></a>Mercer J, Helenius A: Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. <i>Science.</i> 2008; <b>320</b>(5875): 5315. <a target=xrefwindow id=d8838e934 href="http://www.ncbi.nlm.nih.gov/pubmed/18436786">PubMed Abstract </a> | <a target=xrefwindow id=d8838e937 href="https://doi.org/10.1126/science.1155164">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1108808">F1000 Recommendation</a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d8838e950 class=n-a></a>Moller-Tank S, Maury W: Ebola virus entry: a curious and complex series of events. <i>PLoS Pathog.</i> 2015; <b>11</b>(4): e100473. <a target=xrefwindow id=d8838e958 href="http://www.ncbi.nlm.nih.gov/pubmed/25928849">PubMed Abstract </a> | <a target=xrefwindow id=d8838e961 href="https://doi.org/10.1371/journal.ppat.1004731">Publisher Full Text </a> | <a target=xrefwindow id=d8838e964 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4415789">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d8838e974 class=n-a></a>Saeed MF, Kolokoltsov AA, Albrecht T, <i> et al.</i>: Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. <i>PLoS Pathog.</i> 2010; <b>6</b>(9): e1001110. <a target=xrefwindow id=d8838e985 href="http://www.ncbi.nlm.nih.gov/pubmed/20862315">PubMed Abstract </a> | <a target=xrefwindow id=d8838e988 href="https://doi.org/10.1371/journal.ppat.1001110">Publisher Full Text </a> | <a target=xrefwindow id=d8838e992 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2940741">Free Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d8838e1001 class=n-a></a>WuDunn D, Spear PG: Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. <i>J Virol.</i> 1989; <b>63</b>(1): 528. <a target=xrefwindow id=d8838e1009 href="http://www.ncbi.nlm.nih.gov/pubmed/2535752">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1012 href="http://www.ncbi.nlm.nih.gov/pmc/articles/247656">Free Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d8838e1021 class=n-a></a>Giroglou T, Florin L, Schfer F, <i> et al.</i>: Human papillomavirus infection requires cell surface heparan sulfate. <i>J Virol.</i> 2001; <b>75</b>(3): 156570. <a target=xrefwindow id=d8838e1032 href="http://www.ncbi.nlm.nih.gov/pubmed/11152531">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1035 href="https://doi.org/10.1128/JVI.75.3.1565-1570.2001">Publisher Full Text </a> | <a target=xrefwindow id=d8838e1039 href="http://www.ncbi.nlm.nih.gov/pmc/articles/114064">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d8838e1048 class=n-a></a>Feldman SA, Hendry RM, Beeler JA: Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G. <i>J Virol.</i> 1999; <b>73</b>(8): 66107. <a target=xrefwindow id=d8838e1056 href="http://www.ncbi.nlm.nih.gov/pubmed/10400758">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1059 href="http://www.ncbi.nlm.nih.gov/pmc/articles/112745">Free Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d8838e1068 class=n-a></a>Klimyte EM, Smith SE, Oreste P, <i> et al.</i>: Inhibition of Human Metapneumovirus Binding to Heparan Sulfate Blocks Infection in Human Lung Cells and Airway Tissues. <i>J Virol.</i> 2016; <b>90</b>(20): 923750. <a target=xrefwindow id=d8838e1079 href="http://www.ncbi.nlm.nih.gov/pubmed/27489270">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1082 href="https://doi.org/10.1128/JVI.01362-16">Publisher Full Text </a> | <a target=xrefwindow id=d8838e1086 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5044844">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d8838e1095 class=n-a></a>Collett MS, Hincks JR, Benschop K, <i> et al.</i>: Antiviral Activity of Pocapavir in a Randomized, Blinded, Placebo-Controlled Human Oral Poliovirus Vaccine Challenge Model. <i>J Infect Dis.</i> 2017; <b>215</b>(3): 335343. <a target=xrefwindow id=d8838e1106 href="http://www.ncbi.nlm.nih.gov/pubmed/27932608">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1109 href="https://doi.org/10.1093/infdis/jiw542">Publisher Full Text </a> | <a target=xrefwindow id=d8838e1113 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5393058">Free Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d8838e1123 class=n-a></a>Ghosh T, Chattopadhyay K, Marschall M, <i> et al.</i>: Focus on antivirally active sulfated polysaccharides: from structure-activity analysis to clinical evaluation. <i>Glycobiology.</i> 2009; <b>19</b>(1): 215. <a target=xrefwindow id=d8838e1134 href="http://www.ncbi.nlm.nih.gov/pubmed/18815291">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1137 href="https://doi.org/10.1093/glycob/cwn092">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d8838e1146 class=n-a></a>Lee E, Pavy M, Young N, <i> et al.</i>: Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses. <i>Antiviral Res.</i> 2006; <b>69</b>(1): 318. <a target=xrefwindow id=d8838e1157 href="http://www.ncbi.nlm.nih.gov/pubmed/16309754">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1160 href="https://doi.org/10.1016/j.antiviral.2005.08.006">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732321240"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8838e1169 class=n-a></a>Cagno V, Andreozzi P, DAlicarnasso M, <i> et al.</i>: Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism. <i>Nat Mater.</i> 2018; <b>17</b>(2): 195203. <a target=xrefwindow id=d8838e1180 href="http://www.ncbi.nlm.nih.gov/pubmed/29251725">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1183 href="https://doi.org/10.1038/nmat5053">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732321240">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d8838e1196 class=n-a></a>Botos I, Wlodawer A: Cyanovirin-N: a sugar-binding antiviral protein with a new twist. <i>Cell Mol Life Sci.</i> 2003; <b>60</b>(2): 27787. <a target=xrefwindow id=d8838e1204 href="http://www.ncbi.nlm.nih.gov/pubmed/12678493">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1207 href="https://doi.org/10.1007/s000180300023">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d8838e1216 class=n-a></a>Barrientos LG, OKeefe BR, Bray M, <i> et al.</i>: Cyanovirin-N binds to the viral surface glycoprotein, GP<sub>1,2</sub> and inhibits infectivity of Ebola virus. <i>Antiviral Res.</i> 2003; <b>58</b>(1): 4756. <a target=xrefwindow id=d8838e1230 href="http://www.ncbi.nlm.nih.gov/pubmed/12719006">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1234 href="https://doi.org/10.1016/S0166-3542(02)00183-3">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d8838e1243 class=n-a></a>Zhou Y, Simmons G: Development of novel entry inhibitors targeting emerging viruses. <i>Expert Rev Anti Infect Ther.</i> 2012; <b>10</b>(10): 112938. <a target=xrefwindow id=d8838e1251 href="http://www.ncbi.nlm.nih.gov/pubmed/23199399">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1254 href="https://doi.org/10.1586/eri.12.104">Publisher Full Text </a> | <a target=xrefwindow id=d8838e1257 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3587779">Free Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13200064"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8838e1267 class=n-a></a>Carette JE, Raaben M, Wong AC, <i> et al.</i>: Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. <i>Nature.</i> 2011; <b>477</b>(7364): 3403. <a target=xrefwindow id=d8838e1278 href="http://www.ncbi.nlm.nih.gov/pubmed/21866103">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1281 href="https://doi.org/10.1038/nature10348">Publisher Full Text </a> | <a target=xrefwindow id=d8838e1285 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3175325">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13200064">F1000 Recommendation</a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d8838e1298 class=n-a></a>Malakhov MP, Aschenbrenner LM, Smee DF, <i> et al.</i>: Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection. <i>Antimicrob Agents Chemother.</i> 2006; <b>50</b>(4): 14709. <a target=xrefwindow id=d8838e1309 href="http://www.ncbi.nlm.nih.gov/pubmed/16569867">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1312 href="https://doi.org/10.1128/AAC.50.4.1470-1479.2006">Publisher Full Text </a> | <a target=xrefwindow id=d8838e1316 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1426979">Free Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717962093"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8838e1325 class=n-a></a>Moss RB, Hansen C, Sanders RL, <i> et al.</i>: A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection. <i>J Infect Dis.</i> 2012; <b>206</b>(12): 184451. <a target=xrefwindow id=d8838e1336 href="http://www.ncbi.nlm.nih.gov/pubmed/23045618">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1339 href="https://doi.org/10.1093/infdis/jis622">Publisher Full Text </a> | <a target=xrefwindow id=d8838e1343 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3570175">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717962093">F1000 Recommendation</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d8838e1356 class=n-a></a>Li F, Ma C, Wang J: Inhibitors targeting the influenza virus hemagglutinin. <i>Curr Med Chem.</i> 2015; <b>22</b>(11): 136182. <a target=xrefwindow id=d8838e1364 href="http://www.ncbi.nlm.nih.gov/pubmed/25723505">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1367 href="https://doi.org/10.2174/0929867322666150227153919">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d8838e1376 class=n-a></a>MacArthur RD, Novak RM: Reviews of anti-infective agents: maraviroc: the first of a new class of antiretroviral agents. <i>Clin Infect Dis.</i> 2008; <b>47</b>(2): 23641. <a target=xrefwindow id=d8838e1384 href="http://www.ncbi.nlm.nih.gov/pubmed/18532888">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1387 href="https://doi.org/10.1086/589289">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d8838e1396 class=n-a></a>Dorr P, Westby M, Dobbs S, <i> et al.</i>: Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. <i>Antimicrob Agents Chemother.</i> 2005; <b>49</b>(11): 472132. <a target=xrefwindow id=d8838e1407 href="http://www.ncbi.nlm.nih.gov/pubmed/16251317">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1410 href="https://doi.org/10.1128/AAC.49.11.4721-4732.2005">Publisher Full Text </a> | <a target=xrefwindow id=d8838e1414 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1280117">Free Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d8838e1424 class=n-a></a>Pastore C, Ramos A, Mosier DE: Intrinsic obstacles to human immunodeficiency virus type 1 coreceptor switching. <i>J Virol.</i> 2004; <b>78</b>(14): 756574. <a target=xrefwindow id=d8838e1432 href="http://www.ncbi.nlm.nih.gov/pubmed/15220431">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1435 href="https://doi.org/10.1128/JVI.78.14.7565-7574.2004">Publisher Full Text </a> | <a target=xrefwindow id=d8838e1438 href="http://www.ncbi.nlm.nih.gov/pmc/articles/434079">Free Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d8838e1447 class=n-a></a>Vermeire K, Bell TW, van Puyenbroeck V, <i> et al.</i>: Signal peptide-binding drug as a selective inhibitor of co-translational protein translocation. <i>PLoS Biol.</i> 2014; <b>12</b>(12): e1002011. <a target=xrefwindow id=d8838e1458 href="http://www.ncbi.nlm.nih.gov/pubmed/25460167">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1461 href="https://doi.org/10.1371/journal.pbio.1002011">Publisher Full Text </a> | <a target=xrefwindow id=d8838e1465 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4251836">Free Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735259693"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8838e1474 class=n-a></a>van Dongen MJP, Kadam RU, Juraszek J, <i> et al.</i>: A small-molecule fusion inhibitor of influenza virus is orally active in mice. <i>Science.</i> 2019; <b>363</b>(641): pii: eaar6221. <a target=xrefwindow id=d8838e1485 href="http://www.ncbi.nlm.nih.gov/pubmed/30846569">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1488 href="https://doi.org/10.1126/science.aar6221">Publisher Full Text </a> | <a target=xrefwindow id=d8838e1492 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6457909">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735259693">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d8838e1505 class=n-a></a>Jae LT, Raaben M, Herbert AS, <i> et al.</i>: Virus entry. Lassa virus entry requires a trigger-induced receptor switch. <i>Science.</i> 2014; <b>344</b>(6191): 150610. <a target=xrefwindow id=d8838e1516 href="http://www.ncbi.nlm.nih.gov/pubmed/24970085">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1519 href="https://doi.org/10.1126/science.1252480">Publisher Full Text </a> | <a target=xrefwindow id=d8838e1523 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4239993">Free Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726724592"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8838e1532 class=n-a></a>Wec AZ, Nyakatura EK, Herbert AS, <i> et al.</i>: A "Trojan horse" bispecific-antibody strategy for broad protection against ebolaviruses. <i>Science.</i> 2016; <b>354</b>(6310): 3504. <a target=xrefwindow id=d8838e1543 href="http://www.ncbi.nlm.nih.gov/pubmed/27608667">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1546 href="https://doi.org/10.1126/science.aag3267">Publisher Full Text </a> | <a target=xrefwindow id=d8838e1550 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5647781">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726724592">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d8838e1563 class=n-a></a>Fabozzi G, Pegu A, Koup RA, <i> et al.</i>: Bispecific antibodies: Potential immunotherapies for HIV treatment. <i>Methods.</i> 2019; <b>154</b>: 11824. <a target=xrefwindow id=d8838e1574 href="http://www.ncbi.nlm.nih.gov/pubmed/30352254">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1577 href="https://doi.org/10.1016/j.ymeth.2018.10.010">Publisher Full Text </a> | <a target=xrefwindow id=d8838e1581 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6348037">Free Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13200956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8838e1591 class=n-a></a>Ct M, Misasi J, Ren T, <i> et al.</i>: Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. <i>Nature.</i> 2011; <b>477</b>(7364): 3448. <a target=xrefwindow id=d8838e1602 href="http://www.ncbi.nlm.nih.gov/pubmed/21866101">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1605 href="https://doi.org/10.1038/nature10380">Publisher Full Text </a> | <a target=xrefwindow id=d8838e1609 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3230319">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13200956">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d8838e1622 class=n-a></a>Buontempo PJ, Cox S, Wright-Minogue J, <i> et al.</i>: SCH 48973: a potent, broad-spectrum, antienterovirus compound. <i>Antimicrob Agents Chemother.</i> 1997; <b>41</b>(6): 12205. <a target=xrefwindow id=d8838e1633 href="http://www.ncbi.nlm.nih.gov/pubmed/9174174">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1636 href="https://doi.org/10.1128/AAC.41.6.1220">Publisher Full Text </a> | <a target=xrefwindow id=d8838e1640 href="http://www.ncbi.nlm.nih.gov/pmc/articles/163890">Free Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d8838e1649 class=n-a></a>Torres-Torres S, Myers AL, Klatte JM, <i> et al.</i>: First use of investigational antiviral drug pocapavir (v-073) for treating neonatal enteroviral sepsis. <i>Pediatr Infect Dis J.</i> 2015; <b>34</b>(1): 524. <a target=xrefwindow id=d8838e1660 href="http://www.ncbi.nlm.nih.gov/pubmed/25229269">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1663 href="https://doi.org/10.1097/INF.0000000000000497">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d8838e1672 class=n-a></a>Smith TJ, Kremer MJ, Luo M, <i> et al.</i>: The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. <i>Science.</i> 1986; <b>233</b>(4770): 128693. <a target=xrefwindow id=d8838e1683 href="http://www.ncbi.nlm.nih.gov/pubmed/3018924">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1686 href="https://doi.org/10.1126/science.3018924">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735964439"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8838e1695 class=n-a></a>Abdelnabi R, Geraets JA, Ma Y, <i> et al.</i>: A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses. <i>PLoS Biol.</i> 2019; <b>17</b>(6): e3000281. <a target=xrefwindow id=d8838e1706 href="http://www.ncbi.nlm.nih.gov/pubmed/31185007">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1709 href="https://doi.org/10.1371/journal.pbio.3000281">Publisher Full Text </a> | <a target=xrefwindow id=d8838e1713 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6559632">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735964439">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735735128"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8838e1726 class=n-a></a>Sun L, Lee H, Thibaut HJ, <i> et al.</i>: Viral engagement with host receptors blocked by a novel class of tryptophan dendrimers that targets the 5-fold-axis of the enterovirus-A71 capsid. <i>PLoS Pathog.</i> 2019; <b>15</b>(5): e1007760. <a target=xrefwindow id=d8838e1737 href="http://www.ncbi.nlm.nih.gov/pubmed/31071193">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1740 href="https://doi.org/10.1371/journal.ppat.1007760">Publisher Full Text </a> | <a target=xrefwindow id=d8838e1744 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6590834">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735735128">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d8838e1758 class=n-a></a>Diehl N, Schaal H: Make yourself at home: viral hijacking of the PI3K/Akt signaling pathway. <i>Viruses.</i> 2013; <b>5</b>(12): 3192212. <a target=xrefwindow id=d8838e1766 href="http://www.ncbi.nlm.nih.gov/pubmed/24351799">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1769 href="https://doi.org/10.3390/v5123192">Publisher Full Text </a> | <a target=xrefwindow id=d8838e1772 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3967167">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d8838e1781 class=n-a></a>Mazzon M, Castro C, Thaa B, <i> et al.</i>: Alphavirus-induced hyperactivation of PI3K/AKT directs pro-viral metabolic changes. <i>PLoS Pathog.</i> 2018; <b>14</b>(1): e1006835. <a target=xrefwindow id=d8838e1792 href="http://www.ncbi.nlm.nih.gov/pubmed/29377936">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1795 href="https://doi.org/10.1371/journal.ppat.1006835">Publisher Full Text </a> | <a target=xrefwindow id=d8838e1799 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5805360">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d8838e1808 class=n-a></a>Mercer J, Knbel S, Schmidt FI, <i> et al.</i>: Vaccinia virus strains use distinct forms of macropinocytosis for host-cell entry. <i>Proc Natl Acad Sci U S A.</i> 2010; <b>107</b>(20): 934651. <a target=xrefwindow id=d8838e1819 href="http://www.ncbi.nlm.nih.gov/pubmed/20439710">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1822 href="https://doi.org/10.1073/pnas.1004618107">Publisher Full Text </a> | <a target=xrefwindow id=d8838e1826 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2889119">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d8838e1835 class=n-a></a>Dutta D, Williamson CD, Cole NB, <i> et al.</i>: Pitstop 2 is a potent inhibitor of clathrin-independent endocytosis. <i>PLoS One.</i> 2012; <b>7</b>(9): e45799. <a target=xrefwindow id=d8838e1846 href="http://www.ncbi.nlm.nih.gov/pubmed/23029248">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1849 href="https://doi.org/10.1371/journal.pone.0045799">Publisher Full Text </a> | <a target=xrefwindow id=d8838e1853 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3448704">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1032660"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8838e1862 class=n-a></a>Macia E, Ehrlich M, Massol R, <i> et al.</i>: Dynasore, a cell-permeable inhibitor of dynamin. <i>Dev Cell.</i> 2006; <b>10</b>(6): 83950. <a target=xrefwindow id=d8838e1873 href="http://www.ncbi.nlm.nih.gov/pubmed/16740485">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1876 href="https://doi.org/10.1016/j.devcel.2006.04.002">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1032660">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d8838e1889 class=n-a></a>McCluskey A, Daniel JA, Hadzic G, <i> et al.</i>: Building a better dynasore: the dyngo compounds potently inhibit dynamin and endocytosis. <i>Traffic.</i> 2013; <b>14</b>(12): 127289. <a target=xrefwindow id=d8838e1900 href="http://www.ncbi.nlm.nih.gov/pubmed/24025110">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1903 href="https://doi.org/10.1111/tra.12119">Publisher Full Text </a> | <a target=xrefwindow id=d8838e1907 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4138991">Free Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13294022"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8838e1917 class=n-a></a>Harper CB, Martin S, Nguyen TH, <i> et al.</i>: Dynamin inhibition blocks botulinum neurotoxin type A endocytosis in neurons and delays botulism. <i>J Biol Chem.</i> 2011; <b>286</b>(41): 3596676. <a target=xrefwindow id=d8838e1928 href="http://www.ncbi.nlm.nih.gov/pubmed/21832053">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1931 href="https://doi.org/10.1074/jbc.M111.283879">Publisher Full Text </a> | <a target=xrefwindow id=d8838e1935 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3195592">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13294022">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d8838e1948 class=n-a></a>de Wilde AH, Jochmans D, Posthuma CC, <i> et al.</i>: Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. <i>Antimicrob Agents Chemother.</i> 2014; <b>58</b>(8): 487584. <a target=xrefwindow id=d8838e1959 href="http://www.ncbi.nlm.nih.gov/pubmed/24841269">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1962 href="https://doi.org/10.1128/AAC.03011-14">Publisher Full Text </a> | <a target=xrefwindow id=d8838e1966 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4136071">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d8838e1975 class=n-a></a>Blaising J, Lvy PL, Polyak SJ, <i> et al.</i>: Arbidol inhibits viral entry by interfering with clathrin-dependent trafficking. <i>Antiviral Res.</i> 2013; <b>100</b>(1): 2159. <a target=xrefwindow id=d8838e1986 href="http://www.ncbi.nlm.nih.gov/pubmed/23981392">PubMed Abstract </a> | <a target=xrefwindow id=d8838e1989 href="https://doi.org/10.1016/j.antiviral.2013.08.008">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d8838e1998 class=n-a></a>Mazzon M, Ortega-Prieto AM, Imrie D, <i> et al.</i>: Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry. <i>Viruses.</i> 2019; <b>11</b>(2): pii: E176. <a target=xrefwindow id=d8838e2009 href="http://www.ncbi.nlm.nih.gov/pubmed/30791609">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2012 href="https://doi.org/10.3390/v11020176">Publisher Full Text </a> | <a target=xrefwindow id=d8838e2016 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6410080">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d8838e2025 class=n-a></a>Banbury DN, Oakley JD, Sessions RB, <i> et al.</i>: Tyrphostin A23 inhibits internalization of the transferrin receptor by perturbing the interaction between tyrosine motifs and the medium chain subunit of the AP-2 adaptor complex. <i>J Biol Chem.</i> 2003; <b>278</b>(14): 120228. <a target=xrefwindow id=d8838e2036 href="http://www.ncbi.nlm.nih.gov/pubmed/12556528">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2039 href="https://doi.org/10.1074/jbc.M211966200">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d8838e2048 class=n-a></a>Dejonghe W, Kuenen S, Mylle E, <i> et al.</i>: Mitochondrial uncouplers inhibit clathrin-mediated endocytosis largely through cytoplasmic acidification. <i>Nat Commun.</i> 2016; <b>7</b>: 11710. <a target=xrefwindow id=d8838e2059 href="http://www.ncbi.nlm.nih.gov/pubmed/27271794">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2062 href="https://doi.org/10.1038/ncomms11710">Publisher Full Text </a> | <a target=xrefwindow id=d8838e2066 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4899852">Free Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d8838e2076 class=n-a></a>Jurgeit A, McDowell R, Moese S, <i> et al.</i>: Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects. <i>PLoS Pathog.</i> 2012; <b>8</b>(10): e1002976. <a target=xrefwindow id=d8838e2087 href="http://www.ncbi.nlm.nih.gov/pubmed/23133371">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2090 href="https://doi.org/10.1371/journal.ppat.1002976">Publisher Full Text </a> | <a target=xrefwindow id=d8838e2094 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3486884">Free Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d8838e2103 class=n-a></a>HAYES WJ, LAWS JR: Classes of pesticides. In: LAWS H. (ed.) <i>Handbook of Pesticide Toxicology</i>. New york, NY: Academic press. 1991. <a target=xrefwindow id=d8838e2108 href="https://doi.org/10.1016/C2009-0-02709-3">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d8838e2117 class=n-a></a>Doms RW, Moore JP: HIV-1 membrane fusion: targets of opportunity. <i>J Cell Biol.</i> 2000; <b>151</b>(2): F914. <a target=xrefwindow id=d8838e2125 href="http://www.ncbi.nlm.nih.gov/pubmed/11038194">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2128 href="https://doi.org/10.1083/jcb.151.2.f9">Publisher Full Text </a> | <a target=xrefwindow id=d8838e2131 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2192632">Free Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d8838e2140 class=n-a></a>Kaufmann SHE, Dorhoi A, Hotchkiss RS, <i> et al.</i>: Host-directed therapies for bacterial and viral infections. <i>Nat Rev Drug Discov.</i> 2018; <b>17</b>(1): 3556. <a target=xrefwindow id=d8838e2151 href="http://www.ncbi.nlm.nih.gov/pubmed/28935918">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2154 href="https://doi.org/10.1038/nrd.2017.162">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d8838e2163 class=n-a></a>Savarino A, Boelaert JR, Cassone A, <i> et al.</i>: Effects of chloroquine on viral infections: an old drug against today's diseases? <i>Lancet Infect Dis.</i> 2003; <b>3</b>(11): 7227. <a target=xrefwindow id=d8838e2174 href="http://www.ncbi.nlm.nih.gov/pubmed/14592603">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2177 href="https://doi.org/10.1016/S1473-3099(03)00806-5">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d8838e2186 class=n-a></a>Long J, Wright E, Molesti E, <i> et al.</i>: Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry [version 2; peer review: 2 approved]. <i>F1000Res.</i> 2015; <b>4</b>: 30. <a target=xrefwindow id=d8838e2197 href="http://www.ncbi.nlm.nih.gov/pubmed/26069727">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2200 href="https://doi.org/10.12688/f1000research.6085.2">Publisher Full Text </a> | <a target=xrefwindow id=d8838e2204 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4431382">Free Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d8838e2214 class=n-a></a>Nicholson KG, Wiselka MJ: Amantadine for influenza A. <i>BMJ.</i> 1991; <b>302</b>(6774): 4256. <a target=xrefwindow id=d8838e2222 href="http://www.ncbi.nlm.nih.gov/pubmed/2004163">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2225 href="https://doi.org/10.1136/bmj.302.6774.425">Publisher Full Text </a> | <a target=xrefwindow id=d8838e2228 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1669349">Free Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d8838e2237 class=n-a></a>Monto AS, Arden NH: Implications of Viral Resistance to Amantadine in Control of Influenza A. <i>Clin Infect Dis.</i> 1992; <b>15</b>(2): 3627. <a target=xrefwindow id=d8838e2245 href="http://www.ncbi.nlm.nih.gov/pubmed/1520770">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2248 href="https://doi.org/10.1093/clinids/15.2.362">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d8838e2257 class=n-a></a>Schornberg K, Matsuyama S, Kabsch K, <i> et al.</i>: Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. <i>J Virol.</i> 2006; <b>80</b>(8): 41748. <a target=xrefwindow id=d8838e2268 href="http://www.ncbi.nlm.nih.gov/pubmed/16571833">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2271 href="https://doi.org/10.1128/JVI.80.8.4174-4178.2006">Publisher Full Text </a> | <a target=xrefwindow id=d8838e2275 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1440424 ">Free Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725369685"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8838e2284 class=n-a></a>Sakurai Y, Kolokoltsov AA, Chen CC, <i> et al.</i>: Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment. <i>Science.</i> 2015; <b>347</b>(6225): 9958. <a target=xrefwindow id=d8838e2295 href="http://www.ncbi.nlm.nih.gov/pubmed/25722412">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2298 href="https://doi.org/10.1126/science.1258758">Publisher Full Text </a> | <a target=xrefwindow id=d8838e2302 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4550587">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725369685">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d8838e2315 class=n-a></a>Xiao JH, Rijal P, Schimanski L, <i> et al.</i>: Characterization of Influenza Virus Pseudotyped with Ebolavirus Glycoprotein. <i>J Virol.</i> 2018; <b>92</b>(4): pii: e00941-17. <a target=xrefwindow id=d8838e2326 href="http://www.ncbi.nlm.nih.gov/pubmed/29212933">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2329 href="https://doi.org/10.1128/JVI.00941-17">Publisher Full Text </a> | <a target=xrefwindow id=d8838e2333 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5790926">Free Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d8838e2342 class=n-a></a>Penny CJ, Vassileva K, Jha A, <i> et al.</i>: Mining of Ebola virus entry inhibitors identifies approved drugs as two-pore channel pore blockers. <i>Biochim Biophys Acta Mol Cell Res.</i> 2019; <b>1866</b>(7): 11511161. <a target=xrefwindow id=d8838e2353 href="http://www.ncbi.nlm.nih.gov/pubmed/30408544 ">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2356 href="https://doi.org/10.1016/j.bbamcr.2018.10.022">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733835801"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8838e2366 class=n-a></a>Gunaratne GS, Yang Y, Li F, <i> et al.</i>: NAADP-dependent Ca<sup>2+</sup> signaling regulates Middle East respiratory syndrome-coronavirus pseudovirus translocation through the endolysosomal system. <i>Cell Calcium.</i> 2018; <b>75</b>: 3041. <a target=xrefwindow id=d8838e2380 href="http://www.ncbi.nlm.nih.gov/pubmed/30121440">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2384 href="https://doi.org/10.1016/j.ceca.2018.08.003">Publisher Full Text </a> | <a target=xrefwindow id=d8838e2387 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6251489">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733835801">F1000 Recommendation</a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727504873"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8838e2400 class=n-a></a>Nelson EA, Dyall J, Hoenen T, <i> et al.</i>: The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection. <i>PLoS Negl Trop Dis.</i> 2017; <b>11</b>(4): e0005540. <a target=xrefwindow id=d8838e2411 href="http://www.ncbi.nlm.nih.gov/pubmed/28403145">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2414 href="https://doi.org/10.1371/journal.pntd.0005540">Publisher Full Text </a> | <a target=xrefwindow id=d8838e2418 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5402990">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727504873">F1000 Recommendation</a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d8838e2431 class=n-a></a>Hover S, King B, Hall B, <i> et al.</i>: Modulation of Potassium Channels Inhibits Bunyavirus Infection. <i>J Biol Chem.</i> 2016; <b>291</b>(7): 341122. <a target=xrefwindow id=d8838e2442 href="http://www.ncbi.nlm.nih.gov/pubmed/26677217">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2445 href="https://doi.org/10.1074/jbc.M115.692673">Publisher Full Text </a> | <a target=xrefwindow id=d8838e2449 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4751384">Free Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d8838e2458 class=n-a></a>Fung HB, Guo Y: Enfuvirtide: a fusion inhibitor for the treatment of HIV infection. <i>Clin Ther.</i> 2004; <b>26</b>(3): 35278. <a target=xrefwindow id=d8838e2466 href="http://www.ncbi.nlm.nih.gov/pubmed/15110129">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2469 href="https://doi.org/10.1016/S0149-2918(04)90032-X">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725996447"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8838e2478 class=n-a></a>Battles MB, Langedijk JP, Furmanova-Hollenstein P, <i> et al.</i>: Molecular mechanism of respiratory syncytial virus fusion inhibitors. <i>Nat Chem Biol.</i> 2016; <b>12</b>(2): 8793. <a target=xrefwindow id=d8838e2489 href="http://www.ncbi.nlm.nih.gov/pubmed/26641933">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2492 href="https://doi.org/10.1038/nchembio.1982">Publisher Full Text </a> | <a target=xrefwindow id=d8838e2496 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4731865">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725996447">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727865799"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8838e2509 class=n-a></a>Roymans D, Alnajjar SS, Battles MB, <i> et al.</i>: Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor. <i>Nat Commun.</i> 2017; <b>8</b>(1): 167. <a target=xrefwindow id=d8838e2520 href="http://www.ncbi.nlm.nih.gov/pubmed/28761099">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2523 href="https://doi.org/10.1038/s41467-017-00170-x">Publisher Full Text </a> | <a target=xrefwindow id=d8838e2527 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5537225">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727865799">F1000 Recommendation</a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d8838e2541 class=n-a></a>Mathieu C, Huey D, Jurgens E, <i> et al.</i>: Prevention of measles virus infection by intranasal delivery of fusion inhibitor peptides. <i>J Virol.</i> 2015; <b>89</b>(2): 114355. <a target=xrefwindow id=d8838e2552 href="http://www.ncbi.nlm.nih.gov/pubmed/25378493">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2555 href="https://doi.org/10.1128/JVI.02417-14">Publisher Full Text </a> | <a target=xrefwindow id=d8838e2559 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4300632">Free Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/5972956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8838e2568 class=n-a></a>Porotto M, Rockx B, Yokoyama CC, <i> et al.</i>: Inhibition of Nipah Virus Infection In Vivo: Targeting an Early Stage of Paramyxovirus Fusion Activation during Viral Entry. <i>PLoS Pathog.</i> 2010; <b>6</b>(10): e1001168. <a target=xrefwindow id=d8838e2579 href="http://www.ncbi.nlm.nih.gov/pubmed/21060819">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2582 href="https://doi.org/10.1371/journal.ppat.1001168">Publisher Full Text </a> | <a target=xrefwindow id=d8838e2586 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2965769">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/5972956">F1000 Recommendation</a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733623487"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8838e2599 class=n-a></a>Chao LH, Jang J, Johnson A, <i> et al.</i>: How small-molecule inhibitors of dengue-virus infection interfere with viral membrane fusion. <i>eLife.</i> 2018; <b>7</b>: pii: e36461. <a target=xrefwindow id=d8838e2610 href="http://www.ncbi.nlm.nih.gov/pubmed/29999491">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2613 href="https://doi.org/10.7554/eLife.36461">Publisher Full Text </a> | <a target=xrefwindow id=d8838e2617 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6056230">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733623487">F1000 Recommendation</a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d8838e2630 class=n-a></a>Schmidt AG, Yang PL, Harrison SC: Peptide Inhibitors of Flavivirus Entry Derived from the E Protein Stem. <i>J Virol.</i> 2010; <b>84</b>(24): 1254954. <a target=xrefwindow id=d8838e2638 href="http://www.ncbi.nlm.nih.gov/pubmed/20881042">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2641 href="https://doi.org/10.1128/JVI.01440-10">Publisher Full Text </a> | <a target=xrefwindow id=d8838e2644 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3004314">Free Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d8838e2653 class=n-a></a>Stiasny K, Heinz FX: Effect of Membrane Curvature-Modifying Lipids on Membrane Fusion by Tick-Borne Encephalitis Virus. <i>J Virol.</i> 2004; <b>78</b>(16): 853642. <a target=xrefwindow id=d8838e2661 href="http://www.ncbi.nlm.nih.gov/pubmed/15280462">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2664 href="https://doi.org/10.1128/JVI.78.16.8536-8542.2004">Publisher Full Text </a> | <a target=xrefwindow id=d8838e2667 href="http://www.ncbi.nlm.nih.gov/pmc/articles/479076">Free Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d8838e2676 class=n-a></a>McMahon HT, Boucrot E: Membrane curvature at a glance. <i>J Cell Sci.</i> 2015; <b>128</b>(6): 106570. <a target=xrefwindow id=d8838e2684 href="http://www.ncbi.nlm.nih.gov/pubmed/25774051">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2687 href="https://doi.org/10.1242/jcs.114454">Publisher Full Text </a> | <a target=xrefwindow id=d8838e2690 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4359918">Free Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d8838e2700 class=n-a></a>Weston S, Czieso S, White IJ, <i> et al.</i>: Alphavirus Restriction by IFITM Proteins. <i>Traffic.</i> 2016; <b>17</b>(9): 9971013. <a target=xrefwindow id=d8838e2711 href="http://www.ncbi.nlm.nih.gov/pubmed/27219333">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2714 href="https://doi.org/10.1111/tra.12416">Publisher Full Text </a> | <a target=xrefwindow id=d8838e2718 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5025721">Free Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d8838e2727 class=n-a></a>Smith S, Weston S, Kellam P, <i> et al.</i>: IFITM proteins-cellular inhibitors of viral entry. <i>Curr Opin Virol.</i> 2014; <b>4</b>: 717. <a target=xrefwindow id=d8838e2738 href="http://www.ncbi.nlm.nih.gov/pubmed/24480526">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2741 href="https://doi.org/10.1016/j.coviro.2013.11.004">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736185701"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8838e2750 class=n-a></a>Buchrieser J, Degrelle SA, Couderc T, <i> et al.</i>: IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise. <i>Science.</i> 2019; <b>365</b>(6449): 176180. <a target=xrefwindow id=d8838e2761 href="http://www.ncbi.nlm.nih.gov/pubmed/31296770">PubMed Abstract </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736185701">F1000 Recommendation</a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718030692"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8838e2774 class=n-a></a>Johansen LM, Brannan JM, Delos SE, <i> et al.</i>: FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection. <i>Sci Transl Med.</i> 2013; <b>5</b>(190): 190ra79. <a target=xrefwindow id=d8838e2785 href="http://www.ncbi.nlm.nih.gov/pubmed/23785035">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2788 href="https://doi.org/10.1126/scitranslmed.3005471">Publisher Full Text </a> | <a target=xrefwindow id=d8838e2792 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3955358">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718030692">F1000 Recommendation</a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d8838e2805 class=n-a></a>Salata C, Baritussio A, Munegato D, <i> et al.</i>: Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process. <i>Pathog Dis.</i> 2015; <b>73</b>(5): pii: ftv032. <a target=xrefwindow id=d8838e2816 href="http://www.ncbi.nlm.nih.gov/pubmed/25933611">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2819 href="https://doi.org/10.1093/femspd/ftv032">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d8838e2828 class=n-a></a>Turone F: Doctors trial amiodarone for Ebola in Sierra Leone. <i>BMJ.</i> 2014; <b>349</b>: g7198. <a target=xrefwindow id=d8838e2836 href="http://www.ncbi.nlm.nih.gov/pubmed/25429872">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2839 href="https://doi.org/10.1136/bmj.g7198">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d8838e2849 class=n-a></a>Han Y, Mesplde T, Xu H, <i> et al.</i>: The antimalarial drug amodiaquine possesses anti-ZIKA virus activities <i>J Med Virol.</i> 2018; <b>90</b>(5): 796802. <a target=xrefwindow id=d8838e2860 href="http://www.ncbi.nlm.nih.gov/pubmed/29315671">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2863 href="https://doi.org/10.1002/jmv.25031">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718172855"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8838e2872 class=n-a></a>Vigant F, Lee J, Hollmann A, <i> et al.</i>: A Mechanistic Paradigm for Broad-Spectrum Antivirals that Target Virus-Cell Fusion. <i>PLoS Pathog.</i> 2013; <b>9</b>(4): e1003297. <a target=xrefwindow id=d8838e2883 href="http://www.ncbi.nlm.nih.gov/pubmed/23637597">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2886 href="https://doi.org/10.1371/journal.ppat.1003297">Publisher Full Text </a> | <a target=xrefwindow id=d8838e2890 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3630091">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718172855">F1000 Recommendation</a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/2513957"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8838e2903 class=n-a></a>Wolf MC, Freiberg AN, Zhang T, <i> et al.</i>: A broad-spectrum antiviral targeting entry of enveloped viruses. <i>Proc Natl Acad Sci U S A.</i> 2010; <b>107</b>(7): 315762. <a target=xrefwindow id=d8838e2914 href="http://www.ncbi.nlm.nih.gov/pubmed/20133606">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2917 href="https://doi.org/10.1073/pnas.0909587107">Publisher Full Text </a> | <a target=xrefwindow id=d8838e2921 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2840368">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/2513957">F1000 Recommendation</a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d8838e2934 class=n-a></a>Zhu JD, Meng W, Wang XJ, <i> et al.</i>: Broad-spectrum antiviral agents. <i>Front Microbiol.</i> 2015; <b>6</b>: 517. <a target=xrefwindow id=d8838e2945 href="http://www.ncbi.nlm.nih.gov/pubmed/26052325">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2948 href="https://doi.org/10.3389/fmicb.2015.00517">Publisher Full Text </a> | <a target=xrefwindow id=d8838e2952 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4440912">Free Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736511922"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8838e2961 class=n-a></a>Lu DY, Wu HY, Yarla NS, <i> et al.</i>: HAART in HIV/AIDS Treatments: Future Trends. <i>Infect Disord Drug Targets.</i> 2018; <b>18</b>(1): 1522. <a target=xrefwindow id=d8838e2972 href="http://www.ncbi.nlm.nih.gov/pubmed/28474549">PubMed Abstract </a> | <a target=xrefwindow id=d8838e2975 href="https://doi.org/10.2174/1871526517666170505122800">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736511922">F1000 Recommendation</a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d8838e2988 class=n-a></a>Ford N, Shubber Z, Calmy A, <i> et al.</i>: Choice of Antiretroviral Drugs for Postexposure Prophylaxis for Adults and Adolescents: A Systematic Review. <i>Clin Infect Dis.</i> 2015; <b>60 Suppl 3</b>: S170S176. <a target=xrefwindow id=d8838e2999 href="http://www.ncbi.nlm.nih.gov/pubmed/25972499">PubMed Abstract </a> | <a target=xrefwindow id=d8838e3002 href="https://doi.org/10.1093/cid/civ092">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d8838e3012 class=n-a></a>Kirby BJ, Symonds WT, Kearney BP, <i> et al.</i>: Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of the Hepatitis C Virus NS5B Polymerase Inhibitor Sofosbuvir. <i>Clin Pharmacokinet.</i> 2015; <b>54</b>(7): 67790. <a target=xrefwindow id=d8838e3023 href="http://www.ncbi.nlm.nih.gov/pubmed/25822283">PubMed Abstract </a> | <a target=xrefwindow id=d8838e3026 href="https://doi.org/10.1007/s40262-015-0261-7">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d8838e3035 class=n-a></a>Bekerman E, Einav S: Infectious disease. Combating emerging viral threats. <i>Science.</i> 2015; <b>348</b>(6232): 2823. <a target=xrefwindow id=d8838e3043 href="http://www.ncbi.nlm.nih.gov/pubmed/25883340">PubMed Abstract </a> | <a target=xrefwindow id=d8838e3046 href="https://doi.org/ 10.1126/science.aaa3778">Publisher Full Text </a> | <a target=xrefwindow id=d8838e3049 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4419706">Free Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d8838e3058 class=n-a></a>Cross RW, Mire CE, Feldmann H, <i> et al.</i>: Post-exposure treatments for Ebola and Marburg virus infections. <i>Nat Rev Drug Discov.</i> 2018; <b>17</b>: 41334. <a target=xrefwindow id=d8838e3069 href="http://www.ncbi.nlm.nih.gov/pubmed/29725132">PubMed Abstract </a> | <a target=xrefwindow id=d8838e3072 href="https://doi.org/10.1038/nrd.2018.73">Publisher Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d8838e3081 class=n-a></a>de La Vega MA, Caleo G, Audet J, <i> et al.</i>: Ebola viral load at diagnosis associates with patient outcome and outbreak evolution. <i>J Clin Invest.</i> 2015; <b>125</b>(12): 44218. <a target=xrefwindow id=d8838e3092 href="http://www.ncbi.nlm.nih.gov/pubmed/26551677">PubMed Abstract </a> | <a target=xrefwindow id=d8838e3095 href="https://doi.org/10.1172/JCI83162">Publisher Full Text </a> | <a target=xrefwindow id=d8838e3099 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4665775">Free Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726824076"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8838e3108 class=n-a></a>Thi EP, Lee ACH, Geisbert JB, <i> et al.</i>: Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA. <i>Nat Microbiol.</i> 2016; <b>1</b>(10): 16142. <a target=xrefwindow id=d8838e3119 href="http://www.ncbi.nlm.nih.gov/pubmed/27670117">PubMed Abstract </a> | <a target=xrefwindow id=d8838e3122 href="https://doi.org/10.1038/nmicrobiol.2016.142">Publisher Full Text </a> | <a target=xrefwindow id=d8838e3126 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5154560">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726824076">F1000 Recommendation</a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d8838e3139 class=n-a></a>Vaughn DW, Green S, Kalayanarooj S, <i> et al.</i>: Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity. <i>J Infect Dis.</i> 2000; <b>181</b>(1): 29. <a target=xrefwindow id=d8838e3150 href="http://www.ncbi.nlm.nih.gov/pubmed/10608744">PubMed Abstract </a> | <a target=xrefwindow id=d8838e3153 href="https://doi.org/10.1086/315215">Publisher Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d8838e3163 class=n-a></a>Dwek RA, Butters TD, Platt FM, <i> et al.</i>: Targeting glycosylation as a therapeutic approach. <i>Nat Rev Drug Discov.</i> 2002; <b>1</b>(1): 6575. <a target=xrefwindow id=d8838e3174 href="http://www.ncbi.nlm.nih.gov/pubmed/12119611">PubMed Abstract </a> | <a target=xrefwindow id=d8838e3177 href="https://doi.org/10.1038/nrd708">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 12 Sep 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-1628&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-1628&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> MRC Laboratory for Molecular Cell Biology, University College London, London, UK<br/> <p> <div class=margin-bottom> Michela Mazzon <br/> <span>Roles: </span> Conceptualization, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Mark Marsh <br/> <span>Roles: </span> Conceptualization, Funding Acquisition, Supervision, Writing  Original Draft Preparation, Writing  Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/8-1628/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 12 Sep 2019, 8:1628 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.19694.1">https://doi.org/10.12688/f1000research.19694.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2019 Mazzon M and Marsh M. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=21600 data-id=19694 data-downloads="" data-views="" data-scholar="10.12688/f1000research.19694.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/8-1628/v1/pdf?article_uuid=4b37e09d-cd84-4ba6-b517-b019c4156973" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.19694.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Mazzon M and Marsh M. Targeting viral entry as a strategy for broad-spectrum antivirals [version 1; peer review: 3 approved] <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):1628 (<a href="https://doi.org/10.12688/f1000research.19694.1" target=_blank>https://doi.org/10.12688/f1000research.19694.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=19694 id=mobile-track-article-signin-19694 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/19694?target=/articles/8-1628"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=21600 /> <input name=articleId type=hidden value=19694 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Jun Wang</strong>, Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Graham Simmons</strong>, Department of Pathology and Laboratory Medicine, University of California, San Francisco , USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Priscilla L Yang</strong>, Department of Microbiology and Immunobiology, Harvard Medical School, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 12 Sep 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-1628&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-1628&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=56436-53253></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=56437-53255></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=56438-53254></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=3><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/8-1628/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>12 Sep 19</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Jun Wang</strong>, Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Graham Simmons</strong>, Department of Pathology and Laboratory Medicine, University of California, San Francisco , USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Priscilla L Yang</strong>, Department of Microbiology and Immunobiology, Harvard Medical School, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/8-1628&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/8-1628/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Targeting viral entry as a strategy for broad-spectrum...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/8-1628/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/8-1628/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/8-1628/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Mazzon M and Marsh M');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/8-1628/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/8-1628",
            templates : {
                twitter : "Targeting viral entry as a strategy for broad-spectrum antivirals. Mazzon M and Marsh M, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/8-1628/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Targeting viral entry as a strategy for broad-spectrum antivirals", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Targeting viral entry as a strategy for broad-spectrum antivirals", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/19694/21600")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "21600");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "53253": 0,
                           "53254": 0,
                           "53255": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "5202d919-1c70-4ccd-85ba-ecf8529d02a3";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-1628.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-1628.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-1628.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/8-1628.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/8-1628.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>